Immunofluorescence analysis demonstrated a significantly elevated presence of CD4+ and CD8+ T cells in the tumor tissues of mice treated with rPRV-iPD-L1 and rPRV-RFP (Figure 6A–C). This evidence concerns the gene CD4 and neoplasm.